Clinical Trials of Radiopharmaceuticals

作者: Per Juul

DOI: 10.1007/978-94-009-6753-3_12

关键词:

摘要: A drug is any substance or product that used intended to be modify explore physiological systems pathological states for the benefit of patient (1). Accordingly radiopharmaceuticals whether scientific investigational purposes diagnostic therapeutic are covered by definition and subject professional principles underlying development drugs in general — including clinical trials. In this respect radiopharmaceutical do not differ from ordinary drugs, whereas particular problems involved concerning mainly latter ones shall discussed.

参考文章(36)
W Grobin, Treatment of Gastric Ulcer. Canadian Medical Association Journal. ,vol. 79, pp. 756- 757 ,(1958)
Lee B. Lusted, Introduction to medical decision making Charles C. Thomas. ,(1968)
Steven L. Fritz, David F. Preston, Joe H. Gallagher, ROC analysis of diagnostic performance in liver scintigraphy The Journal of Nuclear Medicine. ,vol. 22, pp. 121- 128 ,(1981)
Barry A. Siegel, Steven M. Larson, Ralph G. Robinson, Guidelines for the clinical evaluation of radiopharmaceutical drugs. The Journal of Nuclear Medicine. ,vol. 19, pp. 1359- 1362 ,(1978)
Harold O. Conn, Richard P. Spencer, Observer error in liver scans. Gastroenterology. ,vol. 62, pp. 1085- 1090 ,(1972) , 10.1016/S0016-5085(72)80126-4
Charles E. Metz, Basic principles of ROC analysis Seminars in Nuclear Medicine. ,vol. 8, pp. 283- 298 ,(1978) , 10.1016/S0001-2998(78)80014-2
Jennie A. Freiman, Thomas C. Chalmers, Harry Smith, Roy R. Kuebler, The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials. The New England Journal of Medicine. ,vol. 299, pp. 690- 694 ,(1978) , 10.1056/NEJM197809282991304
Lorrin M. Koran, The Reliability of Clinical Methods, Data and Judgments New England Journal of Medicine. ,vol. 293, pp. 642- 646 ,(1975) , 10.1056/NEJM197509252931307